Shipman, C. M., Vanderkerken, K., De Raeve, H., Perry, M., Hijzen, A., Lippitt, J., Green, J., Van Marck, E., Van Camp, B., & Croucher, P. I. (2002). Zoledronic acid prevents the development of myeloma bone disease and increases survival. JOURNAL OF BONE AND MINERAL RESEARCH, 17(7), 1328–1328.

Shipman, C. M., et al. “Zoledronic Acid Prevents the Development of Myeloma Bone Disease and Increases Survival.” JOURNAL OF BONE AND MINERAL RESEARCH, vol. 17, no. 7, JOURNAL OF BONE AND MINERAL RESEARCH, 2002, pp. 1328–28.

Shipman, CM, K Vanderkerken, H De Raeve, M Perry, A Hijzen, J Lippitt, J Green, E Van Marck, B Van Camp, and PI Croucher. 2002. “Zoledronic Acid Prevents the Development of Myeloma Bone Disease and Increases Survival.” JOURNAL OF BONE AND MINERAL RESEARCH 17 (7): 1328–28.